id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
89,,,,,,,,,,,,,,,2024-05-09T17:13:03+06:00,BSH - H11906036451,,Nab Paclitaxel-Carboplatin,2023-04-05,,"NACT AC x 4 from 23.03.21 to 25.05.21> Docetaxel-Carboplatin from 15.06.21 to
12/10/21> (after RT) Gemcitabine-Cisplatin x 6 from 05.03.22 to 07.22 > 08 cycles Capecitabine up to
March 23 > PET review PD > Started Nab Paclitaxel-Carboplatin from 5.04.23 to 14.08.23> Completed
Capecitabine 6 cycle up to March'24",2023-06-07,,2024-04-03,,2023-06-07,,,Breast,85,,BSBSC-240000085,ROZINA AFROSE,1712187987,1979-11-30,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,3rd Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.2- Upper-inner quadrant of breast,Breast,Left,,,Progressed,Alive,PR,,,,,,,,,,,,,,,,,,,,,
